WEBINAR

Causaly Dissected: Early Discovery: From Target Hypothesis to Validated Rationale

In this episode of Causaly Dissected, our scientists will take the early discovery workflows that shape which targets move toward preclinical development — including target identification, target–disease association mapping, disease biology characterization, competitive and translational evidence review, and preclinical evidence synthesis — and dissect them live.

Early discovery decisions depend on the strength of the target rationale. But too often, that rationale is built from a narrow slice of the evidence: a few familiar papers, sequential validation across one target at a time, or a disease biology view that misses important contradictory or enabling data.

The result is not just slower discovery. It is a higher risk of advancing targets without a complete view of disease relevance, translational evidence, competitive precedent, and preclinical rationale.

In this episode of Causaly Dissected, our scientists will take the early discovery workflows that shape which targets move toward preclinical development — including target identification, target–disease association mapping, disease biology characterization, competitive and translational evidence review, and preclinical evidence synthesis — and dissect them live.

You will see how Causaly helps discovery teams build a systematic view of the evidence around a target, compare multiple candidate targets in parallel, surface supporting and contradictory findings, and generate cited rationales that can be scrutinized by scientific teams. You will also see how teams use Causaly to move beyond manual literature searches and rapidly synthesize evidence across publications, mechanisms, pathways, disease biology, biomarkers, models, and therapeutic hypotheses.

This episode includes: